Walleye Capital LLC Ultragenyx Pharmaceutical Inc. Put Options Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$37.42 - $51.61 $325,554 - $449,007	8,700 New	8,700 $357,000
Q4 2023 Feb 14, 2024	SELL	$31.73 - $49.19 $3,173 - $4,919	-100 Reduced 1.56%	6,300 $301,000
Q3 2023 Nov 14, 2023	BUY	$34.92 - $46.66 $223,488 - $298,624	6,400 New	6,400 $228,000
Q1 2023 May 15, 2023	SELL	$36.99 - $48.71 $36,990 - $48,710	-1,000 Reduced 55.56%	800 $32,000
Q4 2022 Feb 14, 2023	BUY	$33.72 - $46.33 $30,348 - $41,697	900 Added 100.0%	1,800 $83,000
Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $35,964 - $59,526	900 New	900 $37,000

325

85.7M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.13B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.